𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Periphilin is a novel interactor of synphilin-1, a protein implicated in Parkinson's disease

✍ Scribed by Anne S. Soehn; Thomas Franck; Saskia Biskup; Emilie Giaime; Christian Melle; Ruth Rott; Daniel Cebo; Hubert Kalbacher; Erwin Ott; Jens Pahnke; Thomas Meitinger; Rejko Krüger; Thomas Gasser; Daniela Berg; Ferdinand von Eggeling; Simone Engelender; Cristine Alves da Costa; Olaf Riess

Book ID
106257310
Publisher
Springer
Year
2009
Tongue
English
Weight
518 KB
Volume
11
Category
Article
ISSN
1364-6745

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Striatal uptake of a novel PET ligand, [
Striatal uptake of a novel PET ligand, [18F]β-CFT, is reduced in early Parkinson's disease
✍ J.O. Rinne; J. Bergman; H. Ruottinen; M. Haaparanta; E. Eronen; V. Oikonen; P. S 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

[18F] beta-CFT is a novel PET ligand for dopamine reuptake sites. In this study, [18F]beta-CFT uptake was studied in nine patients with early Parkinson's disease (PD) without antiparkinsonian medication and in six age-matched controls. The uptake of [18F]beta-CFT was calculated as a (region-cerebell

A novel target for Huntington's disease:
A novel target for Huntington's disease: ERK at the crossroads of signaling : The ERK signaling pathway is implicated in Huntington's disease and its upregulation ameliorates pathology
✍ Bodai, László (author);Marsh, J. Lawrence (author) 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 300 KB 👁 1 views

## Abstract Activating the ERK pathway (extracellular signal‐regulated kinase pathway) has proven beneficial in several models of Huntington's disease (HD), and drugs that are protective in HD models have recently been found to activate ERK. Thus, the ERK cascade may be a potential target for thera